A potential world-changing test developed in Queensland is set to be trialled among 1500 women in the hopes it can be come a general screening tool for deadly ovarian cancer.

Premenopausal women would benefit from a significantly more accurate diagnostic pathway for ovarian cancer, as a new study finds that an advanced ultrasound test, IOTA ADNEX, identified 9 out of 10 ...

AUSTIN, Texas, May 11, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today announced it has signed an ...

Using machine learning, an electronic nose can "smell" early signs of ovarian cancer in the blood. The method is precise and, according to the LiU researchers behind the study, it could eventually be ...

Australian scientists have created a blood test to guide more effective ovarian cancer treatment, by identifying the women more likely to respond to an ovarian cancer treatment known as PARP inhibitor ...

Another challenge facing test designers is that early detection may not necessarily save lives. A crucial factor, and something that is still unknown about the new multi-cancer tests, is whether they ...

FDA approved a PD-L1 companion test to identify patients with ovarian, fallopian tube or primary peritoneal cancer who may receive Keytruda. The U.S. Food and Drug Administration (FDA) has approved PD ...

Here I am, nine years later.’ After being diagnosed with advanced ovarian cancer at 39, Caitlin Delaney is advocating for early detection — and giving other women hope.